Status:
COMPLETED
Immune Dysregulation in Children and Adults With Asthma
Lead Sponsor:
University of New Mexico
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Asthma
Lung Diseases
Eligibility:
All Genders
Up to 100 years
Phase:
NA
Brief Summary
To immunize both normal and asthmatic subjects with a neoantigen, keyhole limpet hemocyanin (KLH) and observe the type of antibody and T cell response that develops.
Detailed Description
BACKGROUND: Asthma is a result of a dysregulated immune response to inhaled antigens. The development of an immune response dominated by T cells (Th2) that secrete interleukin 4 (IL-4) and IL-5 resul...
Eligibility Criteria
Inclusion
- No eligibility criteria
Exclusion
Key Trial Info
Start Date :
December 1 1996
Trial Type :
INTERVENTIONAL
End Date :
November 1 2001
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00135681
Start Date
December 1 1996
End Date
November 1 2001
Last Update
January 15 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.